{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:23:05Z","timestamp":1792819385631,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1559-7","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T20:12:05Z","timestamp":1531426325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1187-593X","authenticated-orcid":false,"given":"Muaiad","family":"Kittaneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Berkelhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"1559_CR1","unstructured":"Pilarski R, Rai K, Cebulla C, et al. BAP1 tumor predisposition syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. Gene reviews. Seattle: University of Washington; 2016."},{"key":"1559_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40364-015-0040-5","volume":"3","author":"S Klebe","year":"2015","unstructured":"Klebe S, Nasu M, Pastorino S, et al. BAP1 hereditary cancer predisposition syndrome: a case report and review of literature. Biomark Res. 2015;3:14.","journal-title":"Biomark Res"},{"key":"1559_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/gcc.22129","volume":"53","author":"R Pilarski","year":"2014","unstructured":"Pilarski R, Cebulla CM, Massengill JB, et al. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes Chromosomes Cancer. 2014;53:177\u201382.","journal-title":"Genes Chromosomes Cancer"},{"key":"1559_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cge.12630","volume":"89","author":"K Rai","year":"2016","unstructured":"Rai K, Pilarski R, Cebulla CM, et al. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clin Genet. 2016;89:285\u201394.","journal-title":"Clin Genet"},{"key":"1559_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, et al. BAP1 and cancer. Nat Rev Cancer. 2013;13:153\u20139.","journal-title":"Nat Rev Cancer"},{"key":"1559_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"30","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITS. J Transl Med. 2012;30:179.","journal-title":"J Transl Med"},{"key":"1559_CR7","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jtho.2016.04.028","volume":"11","author":"Carbone","year":"2016","unstructured":"Carbone, et al. Consensus report of the 2015 Weinman International Conference on mesothelioma. J Thorac Oncol. 2016;11:1246\u201362.","journal-title":"J Thorac Oncol"},{"key":"1559_CR8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43:1022\u20135.","journal-title":"Nat Genet"},{"issue":"12","key":"1559_CR9","doi-asserted-by":"publisher","first-page":"e1005633","DOI":"10.1371\/journal.pgen.1005633","volume":"11","author":"M Carbone","year":"2015","unstructured":"Carbone M, Flores EG, Emi M, Johnson TA, Tsunoda T, Behner D, et al. Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s. PLoS Genet. 2015;11(12):e1005633.","journal-title":"PLoS Genet"},{"issue":"1","key":"1559_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/gcc.22218","volume":"54","author":"M Betti","year":"2015","unstructured":"Betti M, Casalone E, Ferrante D, Romanelli A, Grosso F, Guarrera S, et al. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. Genes Chromosomes Cancer. 2015;54(1):51\u201362.","journal-title":"Genes Chromosomes Cancer."},{"issue":"1","key":"1559_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36(1):76\u201381.","journal-title":"Carcinogenesis."},{"issue":"1","key":"1559_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1073\/pnas.1309085110","volume":"111","author":"H Yu","year":"2014","unstructured":"Yu H, Pak H, Hammond-Martel I, Ghram M, Rodrigue A, Daou S, et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc Natl Acad Sci USA. 2014;111(1):285\u201390.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"16","key":"1559_CR13","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","volume":"74","author":"IH Ismail","year":"2014","unstructured":"Ismail IH, Davidson R, Gagne JP, Xu ZZ, Poirier GG, Hendzel MJ. Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res. 2014;74(16):4282\u201394.","journal-title":"Cancer Res."},{"issue":"7659","key":"1559_CR14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature22798","volume":"546","author":"A Bononi","year":"2017","unstructured":"Bononi A, Giorgi C, Patergnani S, Larson D, Verbruggen K, Tanji M, et al. BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation. Nature. 2017;546(7659):549\u201353.","journal-title":"Nature."},{"issue":"10","key":"1559_CR15","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/cdd.2017.95","volume":"24","author":"A Bononi","year":"2017","unstructured":"Bononi A, Yang H, Giorgi C, Patergnani S, Pellegrini L, Su M, et al. Germline BAP1 mutations induce a Warburg effect. Cell Death Differ. 2017;24(10):1694\u2013704.","journal-title":"Cell Death Differ."},{"issue":"6","key":"1559_CR16","doi-asserted-by":"publisher","first-page":"e2907","DOI":"10.1038\/cddis.2017.293","volume":"8","author":"I Amelio","year":"2017","unstructured":"Amelio I. Genes versus environment: cytoplasmic BAP1 determines the toxic response to environmental stressors in mesothelioma. Cell Death Dis. 2017;8(6):e2907.","journal-title":"Cell Death Dis."},{"issue":"3","key":"1559_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","volume":"54","author":"N Mashtalir","year":"2014","unstructured":"Mashtalir N, Daou S, Barbour H, Sen NN, Gagnon J, Hammond-Martel I, Dar HH, Therrien M, el Affar B, et al. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2ON. Mol Cell. 2014;54(3):392\u2013406. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2014.03.002\n                    \n                   (Epub 2014 Apr 3).","journal-title":"Mol Cell."},{"key":"1559_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","volume":"11","author":"MN Farley","year":"2013","unstructured":"Farley MN, Schmidt LS, Mester JL, et al. A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res. 2013;11:1061\u201371.","journal-title":"Mol Cancer Res"},{"key":"1559_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","volume":"92","author":"T Popova","year":"2013","unstructured":"Popova T, Hebert L, Jacquemin V, et al. Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet. 2013;92:974\u201380.","journal-title":"Am J Hum Genet"},{"key":"1559_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cge.12501","volume":"88","author":"KA Wadt","year":"2015","unstructured":"Wadt KA, Aoude LG, Johansson P, et al. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clin Genet. 2015;88:267\u201372.","journal-title":"Clin Genet"},{"key":"1559_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/cge.12472","volume":"88","author":"A Fouchardiere de la","year":"2015","unstructured":"de la Fouchardiere A, Cabaret O, Savin L, et al. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet. 2015;88:273\u20137.","journal-title":"Clin Genet"},{"key":"1559_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","volume":"153","author":"AM Haugh","year":"2017","unstructured":"Haugh AM, Njauw CN, Bubley JA, et al. Genotypic and phenotypic features of BAP1 cancer syndrome: a report of 8 new families and review of cases in the literature. JAMA Dermatol. 2017;153:999\u20131006.","journal-title":"JAMA Dermatol"},{"key":"1559_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/neuonc\/nox094","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Abedalthagafi M, Vaubel RA, et al. Germline and somatic BAP1 mutations in high-grade rhabdoid meningioma. Neurol Oncol. 2017;19:535\u201345.","journal-title":"Neurol Oncol"},{"key":"1559_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.wneu.2017.10.064","volume":"109","author":"MC Kaszuba","year":"2018","unstructured":"Kaszuba MC, Pulido JS, Folpe AL, et al. Malignant peripheral nerve sheath tumor in a Patient with BAP1 tumor predisposition syndrome. World Neurosurg. 2018;109:362\u20134.","journal-title":"World Neurosurg"},{"key":"1559_CR25","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011;43:1018\u201321.","journal-title":"Nat Genet"},{"key":"1559_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.semdp.2006.08.002","volume":"23","author":"M Carbone","year":"2006","unstructured":"Carbone M, Bedrossian CWM. The pathogenesis of mesothelioma. Seminars Diagn Pathol. 2006;23:56\u201360.","journal-title":"Seminars Diagn Pathol"},{"issue":"11","key":"1559_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.21037\/atm.2017.04.29","volume":"5","author":"M Carbone","year":"2017","unstructured":"Carbone M, Yang H. Mesothelioma: recent highlights. Ann Transl Med. 2017;5(11):238. \n                    https:\/\/doi.org\/10.21037\/atm.2017.04.29\n                    \n                  .","journal-title":"Ann Transl Med"},{"key":"1559_CR28","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","volume":"76","author":"Y Kadariya","year":"2016","unstructured":"Kadariya Y, Cheung M, Xu J, et al. BAP1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline BAP1 mutations. Cancer Res. 2016;76:2836\u201344.","journal-title":"Cancer Res"},{"key":"1559_CR29","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/onc.2015.243","volume":"35","author":"A Napolitano","year":"2016","unstructured":"Napolitano A, Pellegrini L, Dey A, et al. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. 2016;35:1996\u20132002.","journal-title":"Oncogene"},{"issue":"5","key":"1559_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/JTO.0000000000000506","volume":"10","author":"F Baumann","year":"2015","unstructured":"Baumann F, Buck BJ, Metcalf RV, McLaurin BT, Merkler DJ, Carbone M. The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from Southern Nevada. J Thorac Oncol. 2015;10(5):731\u20137.","journal-title":"J Thorac Oncol"},{"key":"1559_CR31","doi-asserted-by":"publisher","first-page":"13618","DOI":"10.1073\/pnas.1105887108","volume":"108","author":"M Carbone","year":"2011","unstructured":"Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, Yang H, Miller A. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci USA. 2011;108:13618\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1559_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S1470-2045(13)70257-2","volume":"14","author":"F Baumann","year":"2013","unstructured":"Baumann F, Ambrosi JP, Carbone M. Asbestos is not just asbestos: an unrecognised health hazard. Lancet Oncol. 2013;14(7):576\u20138.","journal-title":"Lancet Oncol"},{"key":"1559_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","volume":"10","author":"M Lo Iacono","year":"2015","unstructured":"Lo Iacono M, Monica V, Righi L, et al. Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. J Thorac Oncol. 2015;10:492\u20139.","journal-title":"J Thorac Oncol"},{"key":"1559_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","volume":"75","author":"G Guo","year":"2015","unstructured":"Guo G, Chmielecki J, Goparaju C, et al. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res. 2015;75:264\u20139.","journal-title":"Cancer Res"},{"issue":"4","key":"1559_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10(4):565\u201376.","journal-title":"J Thorac Oncol"},{"key":"1559_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48:407\u201316.","journal-title":"Nat Genet"},{"issue":"47","key":"1559_CR37","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1073\/pnas.1612074113","volume":"113","author":"Y Yoshikawa","year":"2016","unstructured":"Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proc Natl Acad Sci USA. 2016;113(47):13432\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1559_CR38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(00)04013-7","volume":"357","author":"I Roushdy-Hammady","year":"2001","unstructured":"Roushdy-Hammady I, Siegel J, Emri S, et al. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 2001;357:444\u20135.","journal-title":"Lancet"},{"key":"1559_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2068","volume":"7","author":"M Carbone","year":"2007","unstructured":"Carbone M, Emri S, Dogan AU, et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer. 2007;7:147\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1559_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.21037\/atm.2017.04.06","volume":"5","author":"SA Emri","year":"2017","unstructured":"Emri SA. The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad. Ann Transl Med. 2017;5(11):239.","journal-title":"Ann Transl Med"},{"key":"1559_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1748-717X-5-104","volume":"5","author":"Steve Heymann","year":"2010","unstructured":"Heymann Steve, Delaloge Suzette, Rahal Arslane, Caron Olivier, Frebourg Thierry, Barreau Lise, Pachet Corinne, Mathieu Marie-Christine, Marsiglia Hugo. C\u00e9line Bourgier Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol. 2010;5:104.","journal-title":"Radiat Oncol."},{"issue":"9","key":"1559_CR42","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","volume":"17","author":"A Villani","year":"2016","unstructured":"Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin D. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11\u00a0year follow-up of a prospective observational study. Lancet Oncol. 2016;17(9):1295\u2013305.","journal-title":"Lancet Oncol."},{"key":"1559_CR43","first-page":"875","volume":"20","author":"M Carbone","year":"2000","unstructured":"Carbone M, Rizzo P, Pass H. Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res. 2000;20:875\u20138.","journal-title":"Anticancer Res."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1559-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1559-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1559-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:10:47Z","timestamp":1562958647000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1559-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1559"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1559-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"30 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"194"}}